Legal Opinion
United States v. Solvay Pharmaceuticals, Inc.
Court of Appeals for the Fifth Circuit
Decided September 12, 2017No. 16-20259 c/w 16-20509PublishedCited by 86 opinions
1Per curiam
John King and Tammy Drummond (collectively, “Relators”) appeal the district court’s grant of summary judgment to Sol-vay Pharmaceuticals, Inc., on their False Claims Act (“FCA”) claims and a subsequent ruling that partly granted court costs to Solvay. For the reasons explained below, we AFFIRM.
I.Background
Relators are both former Solvay sales and marketing employees. They brought this FCA suit against Solvay claiming that Solvay induced false Medicaid claims through a nationwide off-label marketing and kickback scheme to promote three drugs: Luvox, Aceon, and AndroGel. See 31 U.S.C. §…
2Cases cited45 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- McDonnell Douglas Corp. v. GreenSupreme Court of the United States · 1973
- University of Tex. Southwestern Medical Center v. NassarSupreme Court of the United States · 2013
- Gross v. FBL Financial Services, Inc.Supreme Court of the United States · 2009
- Mary Faye Skotak, George Jerry Skotak, and Eric Norman Skotak, Cross-Appellees v. Tenneco Resins, Inc., Cross-AppellantCourt of Appeals for the Fifth Circuit · 1992
40 more not listed; retrieve them via the Exa API.
3Cited by86 opinions
- April Cadena v. El Paso CountyCourt of Appeals for the Fifth Circuit · 2020
- Lashawnda Brown v. Wal-Mart Stores East, L.P., etCourt of Appeals for the Fifth Circuit · 2020
- William Windham v. Harris County, TexasCourt of Appeals for the Fifth Circuit · 2017
- Esteban Garcia v. Professional Contract Svc IncCourt of Appeals for the Fifth Circuit · 2019
- George Clark v. Champion National Sec, Inc.Court of Appeals for the Fifth Circuit · 2020
81 more not listed; retrieve them via the Exa API.